title: Prophylactic Treatment of Migraine.
abstract: Migraine is a common chronic neurological disease characterized by episodic attacks of headache and associated symptoms. The pharmacological treatment of migraine may be acute or prophylactic, and patients with frequent, severe headaches often require both approaches. Prophylactic treatment is used to reduce the frequency, duration, or severity of attacks, to enhance the benefits of acute treatments, and to improve patient's ability to function normally. Prophylactic treatment may also prevent progression from episodic migraine to chronic migraine and may result in reductions in health-care cost. The currently available pharmacological options for migraine prophylaxis include a wide array of medications. The major medication groups for prophylactic treatment include β-blockers, anticonvulsant, drugs such as topiramate and valproate, antidepressant drugs, such as amitriptyline and selective serotonin and selective serotonin-norepinephrine reuptake inhibitors (SNRIs), calcium channel antagonists and neurotoxins. The agent for prophylactic treatment should be chosen based on the efficacy and side-effect profile of the drug, and the patient's coexistent and comorbid conditions.
authors.affiliation: Bezmialem Foundation University, Medical Faculty, Department of Neurology, Istanbul, Turkey.
authors.forename: Azize Esra
authors.initials: AE
authors.lastname: Gürsoy
authors.affiliation: LIV Hospital Ulus Hospital, Neurology Clinic, Istanbul, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Ertaş
keywords: Migraine; prophylactic treatment